Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The object of this trial is to assess the safety and efficacy of a 24 week course of
flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.